<?xml version="1.0" encoding="UTF-8"?>
<p>For example, engineered human SP-D enhanced IAV binding and clearance and murine survival 
 <italic>in vivo</italic> [
 <xref rid="B174" ref-type="bibr">174</xref>]. A recombinant fragment of human SP-D, containing only neck and CRD regions, showed ability to act as virus entry inhibitor as well as ability to down-regulate excessive virus-induced pro-inflammatory responses [
 <xref rid="B175" ref-type="bibr">175</xref>]. Recombinant porcine SP-D (either as the intact protein or as a fragment containing the neck and CRD only) inhibited IAV and IBV infection in epithelial cells of human trachea [
 <xref rid="B94" ref-type="bibr">94</xref>] and A(H3N2) IAV in 
 <italic>ex vivo</italic> cultures of respiratory tract tissue [
 <xref rid="B176" ref-type="bibr">176</xref>,
 <xref rid="B177" ref-type="bibr">177</xref>], and was more effective than recombinant human SP-D.
</p>
